Chimeric protein and nano-construct for tissue-retained enzyme to locally suppress inflammation by Keselowsky, Benjamin et al.
CHIMERIC PROTEIN AND NANO-CONSTRUCT FOR TISSUE-RETAINED ENZYME TO LOCALLY 
SUPPRESS INFLAMMATION 
 
Benjamin G. Keselowsky, University of Florida 
bkeselowsky@bme.ufl.edu 
Evelyn Bracho-Sanchez, University of Florida 
Sabrina Freeman, University of Florida 
Antonietta Restuccia, University of Florida 
Margaret M. Fettis, University of Florida 
Mark A. Wallet, University of Florida 
Fernanda Rocha, University of Florida 
Shannon M. Wallet, University of Florida 
Gregory A. Hudalla, University of Florida 
 
 
Key Words: enzyme; inflammation; self-assembly; nano-construct 
 
There is considerable need for new retention strategies of immunomodulatory biologics for localized 
suppression of inflammation. We developed a chimeric protein as a well as a self-assembled nano-construct 
incorporating novel approaches for both retention and suppression to induce potent, confined metabolic 
programming. Immunosuppressive indoleamine 2,3 dioxygenase (IDO), which depletes tryptophan through the 
kynurenine pathway, was fused to Galectin 3 (Gal3), which binds extracellular glycans and provides tissue 
anchoring. Using a luciferase-Gal3 fusion reporter, tissue retention was prolonged to ~6 d whereas native 
luciferase is not retained and undetectable by 24 h. IDO-Gal3 injected subcutaneously controlled local LPS-
challenged tissue inflammation. Furthermore, subgingival injection suppressed periodontal disease (PD) in a 
polymicrobial challenged mouse model. Multiplex analysis of gingival tissue revealed decreased inflammatory 
(IL-1β, IL-12p70, KC, IP10, MCP1, MIP2) and increased anti-inflammatory (IL-10, TGFβ3) proteins, indicating a 
shift toward homeostasis. Animals treated with IDO-Gal3 also showed significant decrease in bone loss 
commonly associated with PD, as determined by µCT analysis. 
 
